![Enrique Codina Gibert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Enrique Codina Gibert first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pharmacelera SL
![]() Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain.
2
| Holding Company | Information Technology Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Enrique Codina Gibert via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Macrophage Pharma Ltd.
![]() Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Chief Executive Officer | |
SANOFI | Pharmaceuticals: Major | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Proteome Therapeutics, Inc.
![]() Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Biotechnology | Chief Executive Officer | |
GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
General Inception
![]() General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal |
Statistics
International
United States | 4 |
Germany | 2 |
United Kingdom | 2 |
France | 2 |
India | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Finance | 2 |
Operational
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 2 |
Most connected contacts
Insiders | |
---|---|
Venkat Reddy | 9 |
Abellanas Herrero | 1 |
- Stock Market
- Insiders
- Enrique Codina Gibert
- Company connections